May 2015, Vol 5, No 4

FDA-Approved Medications Used for the Treatment of Leukemia

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of leukemia. Read More ›

Akynzeo (Netupitant and Palonosetron), a Dual-Acting Oral Agent, Approved by the FDA for the Prevention of Chemotherapy-Induced Nausea and Vomiting

By Lisa A. Raedler, PhD, RPh

Drug Updates

Trials Under Way for Patients with Melanoma

Clinical Trials Tracker

Seven Steps to Finding the Right Financial Advisor

By W. Ben, Utley, CFP; Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF

Financial Management, Practice Management, Practice Management

Rest in Peace, SGR

By Leah Ralph

Sunitinib Associated with Higher Costs Compared with Pazopanib in Patients with RCC

By Chase Doyle

Drug Updates

Federal Government Outlines Stage 3 of Meaningful Use

By Rosemary Frei, MSc

Reimbursement

Waiting for the Carrot? It May Take a While

By Dawn Holcombe, MBA, FACMPE, ACHE

From the Editor

The Nurse Practitioner’s Role in the Practice

By Peggy Barton, RN

Practice Management

340B Rules Remain in Flux

By Rosemary Frei, MSc

May 2015, Vol 5, No 4

Top Trending Articles

CONNECT

May 2015, Vol 5, No 4

Page 1 of 2

Top Trending Articles

CONNECT